Huma's virtual clinical trial solution connects trial participants, investigators, and research teams to accelerate recruitment, drive participant engagement and protocol adherence. Huma’s technology for clinical trials reduces participant burden and improves the visibility of patient-generated data collected in the real-life setting.
Huma is enabling biopharmaceutical and medical device companies to extract deeper insights into the use and performance of treatments in real world settings, through the collection and analysis of real-world data.
Huma’s digital phenotyping capabilities and digital biomarkers can provide more comprehensive, objective, and continuous pictures of human behavior and function in both health and disease. This data is advancing predictive and personalised medicine, and is improving the precision and speed of clinical trials.
Huma's digital companion products complement existing treatments, by simplifying patient data capture. They also empower and connect patients, clinicians, and healthcare systems to improve the quality of care.
Remote screening and enrollment
Remote data capture and patient monitoring
Remote Patient Management Solutions
Life-cycle management/Phase 4
Track medication adherence
Patient engagement and education
Personalised health insights
Portfolio of clinically-validated digital biomarkers providing more objective, continuous, real-world assessments of disease signs and symptoms, and patient behaviours and outcomes.
Our platform gives life science companies the opportunity to build a longitudinal relationship with a patient population.
From sending out updates to participants who have been involved in studies (e.g. published results and regulatory approvals), to staying in contact with participants for follow-up studies (e.g. market research and RWE studies), Huma's preventative health and digital solutions make research more human-centric.